Composition
Clopidogrel Tablets IP
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Clopiberg contains Clopidogrel, a P2Y12 receptor antagonist that inhibits ADP-mediated platelet aggregation to reduce thrombotic cardiovascular events.
Indication
Acute coronary syndrome, recent MI or stroke, peripheral arterial disease, and dual antiplatelet therapy with aspirin after stent placement.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.